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Abstract: Since the introduction of SPPS by Merrifield in the 60s, peptide chemists have 
considered the possibility of preparing large proteins. The introduction of native chemical 
ligation in the 90s and then of expressed protein ligation have opened the way to the preparation 
of synthetic proteins without size limitations. This review focuses on semi-synthetic strategies 
useful to prepare proteins decorated with spectroscopic probes, like fluorescent labels and 
stable isotopes, and their biophysical applications. We show that expressed protein ligation, 
combining the advantages of organic chemistry with the easy and size limitless recombinant 
protein expression, is an excellent strategy for the chemical synthesis of labeled proteins, 
enabling a single protein to be functionalized at one or even more distinct positions with 
different probes. 
Keywords: expressed protein ligation; intein; Förster resonance energy transfer; segmental 
labeling; NMR; protein labeling 
 
1. Introduction 
Protein structure, folding dynamics, function and interactions with other macromolecules can be widely 
explored and characterized by biophysical techniques such as fluorescence and NMR spectroscopies. 
Spectroscopic techniques rely tightly on protein labeling strategies by which the chemical structure of 
a protein is modified through the introduction of biophysical probes, such as fluorophores or isotopes. 
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A wide collection of protein labeling approaches have been developed in recent years [1–4], leading to 
great discoveries and innovations. In particular, the introduction of native chemical ligation (NCL) 
methodologies for chemical synthesis of proteins marked a breakthrough in protein and peptide 
chemistry, with a strong impact on chemical biology and biophysical applications [5,6]. Here, we 
review the semi-synthetic strategies employed for the preparation of labeled proteins and their 
spectroscopic applications. 
1.1. Total Synthesis of Proteins: SPPS and Chemical Ligation 
The great advantage of chemical protein synthesis and semi-synthesis over traditional recombinant 
protein expression refers to the precise control over the kind and number of modifications that can be 
introduced into a protein molecule, enabling one to realize any desired change of its covalent structure 
with surgical precision. Since the introduction in 1963 of the stepwise solid-phase peptide synthesis 
(SPPS) by Merrifield [7], chemical synthesis of proteins greatly expanded and culminated with the 
development of chemical ligation approaches [8]. Chemical ligation methods allow one to overcome 
the size-limit of SPPS, mainly due to incomplete coupling and deprotection reactions (Figure 1), 
affording the synthesis of large proteins by stitching together short synthetic segments to give a 
polypeptide chain of any desired length and harboring a plethora of possible chemical modifications. 
Figure 1. Dependence of stepwise SPPS yield on coupling efficiency (A) and number of 
coupling steps (B). 
 
In this scope, ligation strategies are based on chemoselective reactions between two functional 
groups respectively placed at N- and C-terminus of two contiguous peptide segments which react by 
forming a stable chemical bond. The type of chemical bond made at the site of junction between two 
peptide fragments depends on the reactive groups employed (Figure 2). For instance, the reaction 
between an hydrazide or an aminooxy group with an aldehyde or a ketone gives rise to hydrazones or 
oximes (Figure 2A,B); a pseudoproline analog results from the reaction between a peptide bearing a  
C-terminal glycolaldehyde ester and a second peptide starting with Cys, Ser or Thr [9,10] (Figure 2C); 
a peptide-thiocarboxylate reacts with a Nα-bromoacetyl-peptide to give a thioester-linked polypeptide 
product (Figure 2D) [8]; the reaction between a thiol and a bromoacetyl group yields a polypeptide 
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joined by thioether linkage (Figure 2E) [11]; thiol and maleimide groups react through a Michael 
addition (Figure 2F) [12]; Cu(I)-catalyzed azide-alkine [3+2] cycloaddition leads to the formation of a 
triazole ring (Figure 2G) [13,14]; Diels-Alder cycloaddition reaction, which involves a diene and a 
dienophile, yields a six member carbocycle (Figure 2H) [15]. 
Figure 2. Schematic representation of chemoselective reactions useful for non-native 
chemical ligation. (A) and (B) R = H, CH3; (C) R = SH, OH. 
 
Even though numerous proteins have been successfully prepared by chemical ligation strategies 
yielding a non-native bond at the junction sites [16,17], such unnatural structures are not always 
compatible with the assumption of correct protein folding. Thus, great efforts were directed towards 
the development of traceless chemical ligation approaches, ending up in the introduction of the NCL 
by Kent and coworkers [18]. This method leads to the formation of a single polypeptide chain bearing 
a native peptide bond at the ligation site after coupling of two peptide segments, one containing a 
carboxy-terminal α-thioester group and the other bearing a 1,2 aminothiol, like an amino-terminal Cys 
residue (Figure 3). The reaction occurs, even under mild conditions (aqueous solution at pH around 
neutrality), through a trans-thioesterification reaction which leads to the formation of a thioester 
intermediate rapidly evolving toward the desired stable amide-linked product through a spontaneous 
intramolecular S-to-N acyl shift. This reaction is orthogonal with respect to functional groups present 
in a protein and also proceeds selectively in the presence of internal Cys residues. Another powerful 
chemical ligation method is the traceless Staudinger ligation, which relies on the selective reaction 
between a phosphinothioester and an azide to form an amide bond [19]. This method does not 
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necessitate of a Cys residue at the junction between two peptide fragments and, thus, appears as a 
strategy complementary to NCL. 
Figure 3. Mechanism of the NCL reaction. 
 
The efficacy of the NCL has been significantly broadened by the introduction of a “recombinant” 
version, named Expressed Protein Ligation (EPL) [20,21]. In this case one or more of the peptide 
building blocks are prepared by recombinant DNA technology and ligated through a NCL reaction 
between a carboxy-terminal α-thioester and 1,2 aminothiol groups. For this reason, EPL is referred to 
as a semi-synthetic approach. To achieve C-terminal thioester or N-terminal Cys containing protein 
segments, EPL exploits a class of proteins called inteins, which are auto-cleavable elements able to 
catalyze their self-removal from flanking polypeptides [21,22]. EPL, as well as NCL, has been employed 
for the introduction into proteins of unnatural amino acids, post-translational modifications [6,20,23,24] 
and covalent dimers formation [25,26]. Furthermore, EPL, combining the advantages of organic chemistry 
with the easy and size limitless recombinant protein expression, allows for the preparation of modified 
large proteins. 
1.2. Protein Synthesis via Intein Chemistry (EPL and PTS) 
The mechanism by which an intein is removed from a pre-mature polypeptide chain is known as 
protein splicing (Figure 4). Protein splicing proceeds through an N→S (or N→O) acyl shift in which 
the N-extein is transferred to the side chain -SH or -OH of a Cys/Ser residue, located at N-terminus of 
the intein. The N-extein is then transferred to a second Cys/Ser residue located at the N-terminus of the 
C-extein through a trans(thio)esterification reaction. A cyclization reaction involving a conserved Asn 
residue at the intein C-terminus leads to intein excision and to the formation of a new peptide bond 
between the two exteins, giving the mature polypeptide chain. A wide number of genetically engineered 
inteins able to catalyze their self-cleavage from only a N- or C-extein have been obtained, providing a 
powerful tool to prepare recombinant C-terminal thioester or N-terminal cysteinyl polypeptides 
required to perform EPL. 
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Figure 4. Mechanism of the intein protein splicing reaction. 
 
To prepare C-terminal thioester proteins, inteins harboring the mutation of the C-terminal Asn into 
an Ala have been designed [22]. Such mutant inteins are unable to evolve from the thioester 
intermediate to the final spliced product. In this case, the thioester intermediate can be cleaved off by 
addition of thiols releasing the N-extein as C-terminal thioester protein (Figure 5A). Several E. coli 
expression vectors are commercially available that allow the recombinant expression of fusion 
constructs with engineered inteins, such as the Saccharomyces cerevisiae vacuolar ATPase subunit 
(Sce VMA) intein, Methanobacterium thermo-autotrophicum ribonucleoside diphosphate reductase 
(Mth RIR1) intein or the Mycobacterium xenopi DNA gyrase A (Mxe GyrA) intein [27]. The Mxe 
GyrA intein [28] is the most widely used as Mxe GyrA intein is small (198 amino acids), expresses at 
high level in bacteria, is able to efficiently refold from inclusion bodies and is cleaved by a variety of 
thiols, even in the presence of low concentration of denaturants (i.e., 2 M urea), detergents or organic 
solvents [29]. Special care has to be devoted to the choice of the -1 residue at the junction extein-intein, 
as the efficiency of splicing is intein and N-extein sequence dependent. Furthermore, the extein sequence 
modulates the kinetic of protein splicing. Notably, a -1 Asp residue induces high levels of premature 
cleavage in vivo, whereas a -1 Pro should be avoided as completely inhibits the cleavage [20,27]. 
The thiol sodium 2-mercaptoethanesulfonate (MESNA) is often employed to mediate intein 
thiolysis. In fact, while thioalkyl-esters, obtained, for example, from ethanedithiol (EDT) and 
ethanethiol (ET), are quite stable, but not reactive enough in NCL, whereas thioaryl-esters, which 
result from the use of benzylmercaptan and thiophenol as splicing inducing agents, are much more 
reactive but even more susceptible to hydrolysis. Usually, an alkyl-thioester is preferred during the 
preparation and purification steps, while during NCL, the addition of aryl-thiols to the reaction mixture 
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allows for conversion of the thioester species into a more reactive thioaryl-ester through trans-
thioesterification. The thiol MESNA allows a good compromise between stability and reactivity of the 
thioester protein obtained. Furthermore, MESNA is a non-malodourous thiol, facilitating thioester protein 
handling and purification. A complete characterization of the reactivity of a wide series of thiols was 
performed by Johnson and Kent [30]. They also reported another useful non-maleodorous thiol, the  
p-mercaptophenylacetic acid (MPAA), which can be added to the NCL mixture to promote the in-situ 
generation of a very reactive thioester, resulting in a sensible improvement in the efficiency both in terms 
of yield and time of reaction. 
Figure 5. Schematic representation of reactions performed by engineered inteins yielding 
α-thioester proteins (A) or N-terminal cysteinyl-proteins (B). 
 
Protein splicing can also be exploited to prepare amino-terminal Cys proteins. In this case, inteins 
have been mutated in order to induce the cleavage at the C-terminal splice junction, between the intein 
and a C-extein starting with Cys, through pH and temperature changes (Figure 5B). Splicing of such 
modified inteins allows for the release of an amino-terminal cysteinyl protein. The Mxe GyrA intein 
was also adapted to this application [27], as well as the Synechocystis sp. PCC6803 DnaB helicase  
(Ssp DnaB) intein [31]. A drawback of this intein-based approach refers to the spontaneous cleavage at 
the intein-extein junction which can occur during expression and purification of the fusion protein. 
Finally, due to their self-removing nature, inteins have been exploited as auto-cleavable fusion partner 
in protease-free purification schemes [32–34]. 
Similarly to EPL, another process called Protein Trans-splicing (PTS) can be employed for the  
site-specific labeling of a protein. Such an approach relies on the use of a particular class of inteins 
which are naturally split or can be split into two pieces and, upon mixing, reassemble into a functional 
intein able to splice. Ligation of the proteins, which can be decorated with functional probes, fused to 
the split inteins occurs after the intein has been reconstituted (Figure 6) [35]. Natural or artificially split 
inteins have been examined to identify different possible sites of splitting. Interestingly, such 
investigations showed that in some inteins, such as Mxe GyrA, Ssp DnaB and Ssp GyrB inteins, the 
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splitting site can be shifted very close to intein termini [36–39], rendering N-terminal or C-terminal 
split intein fragments so short that the preparation of this segments and their exteins can be 
accomplished by SPPS, expanding the repertoire of possible chemical modifications that can be 
introduced into a protein. 
Figure 6. Schematic representation of the protein trans splicing reaction. Target proteins 
(yellow and gray) are fused to N- (IntN, red) and C-terminal (IntC, green) split intein 
fragments. After reconstitution, intein splices releasing the two target proteins linked 
through an amide bond. 
 
2. Fluorescent Labeling 
Tagging proteins with fluorescent probes provides a tool to study proteins both in vivo and in vitro 
by confocal microscopy and fluorescence techniques, such as Förster resonance energy transfer 
(FRET), fluorescence correlation spectroscopy (FCS) and fluorescence polarization (FP). Genetic fusion 
to green fluorescent protein (GFP) and its color burst of spectral variants has allowed elucidation of the 
function of many proteins by mapping their intracellular localization and trafficking [40–44]. 
However, due to their large size, fluorescent fusion partners may interfere with protein folding and 
function. Moreover, fluorescent proteins quantum yield and photostability are quite limited [45]. Thus, 
it could be convenient to replace fluorescent partners with organic dyes [1,46]. Conventional methods 
for protein derivatization with fluorophores exploit the reactivity of native or engineered Lys or  
Cys side chains, as numerous dyes are commercially available as N-hydroxysuccinimide esters, 
isothiocyanates, iodoacetamides, vinyl sulfonones, maleimides and bromo-maleimides that react 
selectively with amino or thiol group [47,48]. However, this approach could be hampered by the 
presence of more than one Cys or Lys in the protein sequence, resulting in multiple labeling and 
heterogeneous protein preparations. Furthermore, many of such approaches suffer of a poor versatility, 
being tailored on a specific protein target [49,50]. Other approaches described are limited to the 
labeling of extra-protein sequence signal peptides, such as the reaction with FlASH, CrAsH or ReASH 
(biarsenical derivatives of fluorescein and resorufin) [51–53], which bind non-covalently to a short 
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hexapeptide containing a tetracysteine motif (CCXXCC, were X stands for any amino acid, preferentially 
Pro or Gly), rhodamine-derived bisboronic acid (RhoBo) dye, which reacts with a tetraserine tag 
sequence (SSPGSS) [54], nickel-nitriloacetic acid derivatized chromophores [55,56], which interact 
with hexa or decahistidine tags, fluorophores complexed to Zn2+-2,2'-dipicoylamine based on L-tyrosine 
scaffold (Zn2+-DpaTyr), which bind to oligoaspartic acid sequence [57]. Enzymatic approaches for 
protein labeling were also described, such as the SNAP-tag [58], CLIP-tag [59] and Halo-tag [60] 
technologies. Other enzymatic strategies require the fusion of the target protein to a short signal 
peptide, such as the reaction catalyzed by sortase [61], transglutaminase [62], biotin-ligase [63], 
phosphopantetheine transferase [64], lipoic acid ligase, myristoyl-CoA:protein N-myristoyltransferase [65]. 
Although of great originality and inventiveness, the above mentioned labeling procedures are limited 
to N- or C-protein termini and generally do not allow incorporation of multiple, different molecular 
probes into a protein. The drawbacks of these fluorescent labeling strategies are successfully overcome 
using chemical ligation approaches, which do not require the addition to the protein of extra-sequence 
signal peptides or labeling domains and ensure open access to any site of any protein sequence with 
unique level of specificity. 
2.1. Protein Labeling with Fluorescent Probes for FRET Studies 
A large number of fluorescent proteins have been prepared by EPL and employed for the 
conduction of structural and functional studies by FRET. FRET can be used to monitor dynamic 
processes involving protein structural changes, protein interaction or oligomerization through the 
variation of the spatial distance between two fluorophores. Relevant examples were reported by Muir, 
who pioneered the field with outstanding works [66–69]. Of great interest is his description of a  
solid-phase expressed protein ligation (SPPL) strategy that enabled the semi-synthesis of a large 
protein on a solid support. The designed approach was exploited to label the N and C termini of the 
Crk-II protein with the fluorescein and tetramethylrhodamine FRET pair. Crk-II was expressed in 
bacteria as fusion construct with the yeast vacuolar membrane ATPase (VMA) intein and with the 
affinity tag chitin binding domain (CBD). The fusion construct harbored an N-terminal Cys masked by the 
proteolysis site recognized by the factor Xa protease. The chimeric protein Xa site-Crk-II-intein-CBD 
was purified from cytosolic extract using a chitin affinity resin. The protein was incubated on the solid 
matrix with a synthetic peptide containing an N-terminal Cys residue and the probes fluorescein (Fl) 
and biotin, separated by the PreScission protease cleavage site (PS). The peptide reacted in an one pot 
reaction with the C-terminal thioester derivative of Crk-II protein, released from VMA intein splicing, 
affording the C-terminal Crk-II labeling with the first dye (Fl). The biotin handle was exploited to 
isolate the EPL product by an affinity chromatography step on an avidin-resin. Once bound to the 
resin, the Xa site-Crk-II-Fl PS biotin was incubated with factor Xa protease, in order to expose the  
N-terminal Cys while leaving the fusion construct attached to the resin. The protein underwent a 
second ligation reaction with a synthethic C-terminal-thioester peptide labeled with tetramethylrhodamine 
(Rd), affording the introduction of the second label. The doubly-labeled construct was cleaved from 
the resin upon incubation with biotin or with the PreScission protease. The latter method allowed the 
removing of the affinity biotin handle, giving the doubly-labeled species Rd-Crk-II-Fl. FRET 
experiments performed on dual labeled Crk-II construct before and after its phosphorylation by the 
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nonreceptor protein tyrosine kinase c-Abl resulted in a variation of FRET efficiency between the dyes 
pair, suggesting conformational changes upon phosphorylation [67]. In a successive work, a doubly 
labeled truncated version of Crk-II that worked as fluorescent biosensor was synthesized, enabling 
real-time monitoring of c-Abl kinase activity and provided a rapid tool for screening potential c-Abl 
kinase inhibitors [68]. A combination of EPL and selective Cys-labeling was employed by the 
Ebright’s group to introduce the FRET pair tetramethylrhodamine and fluorescein into different 
subunits of the E. coli RNA polymerase holoenzyme [70,71]. FRET studies led to the elaboration of a 
structural model for the holoenzyme complex. More recently, Xie et al. used EPL to label the histone 
acetyltransferases (HATs) PCAF and p300 with Dabcyl as FRET acceptor, while HAT substrate 
analogues were labeled with the acceptor dye methoxycoumarin through SPPS. The molecules were 
subjected to FRET and fluorescence anisotropy assays to detect HATs inhibitors [72]. A FRET based 
approach to observe protein oligomerization was described by Scheibner et al. [73]. A synthetic 
dipeptide Cys-Lys(ε-fluorescein) (donor) or Cys-Lys(ε-rhodamine) (acceptor) was attached via EPL to 
the C-terminus of three recombinant proteins (glutathione S-transferase, SH2 domain phosphatase-1 
and serotonin N-acetyltransferase) and a mixture of the two singly-labeled proteins, carrying the donor 
or the acceptor fluorophore, was analyzed by FRET. A similar labeling strategy was adopted in a study 
performed on two GTPases from the superfamily of Ras-like small GTPases, H-Ras and Ypt1, and two 
of their interacting partners, the Ras-binding domain (RBD) of c-Raf1 and MRS6. Target proteins 
were prepared as C-terminal thioester derivatives using intein fusion technology. Thioester proteins 
were reacted with synthetic decapeptides labeled in the solid phase with a flurophore and containing 
six His residues, the latter being useful to purify the ligation products. Labeled proteins were subjected to 
protein-protein and protein-nucleotide interaction studies by FRET and fluorescence cross-correlation 
spectroscopy (FCCS) [74]. Multicolor protein labeling is a useful way for the characterization of 
protein structure and folding by FRET studies. These studies require the attachment of a donor and an 
acceptor dye inside the same polypeptide chain at specific positions. An example of semi-synthetic 
protein doubly labeled with fluorescent dyes was reported by Yi et al. [75]. The described approach is 
limited to protein N- and C-termini and uses a combination of EPL and oxime ligation [76]. Rab7 
GTPase protein was obtained as C-terminal thioester after intein splicing. The thioester protein was 
reacted with (bis)oxyamine moiety. The C-terminal oxamino-modified protein derivative selectively 
reacts with fluorophores containing a ketone functional group. To afford the second labeling, an  
N-terminal Cys residue was exposed by Tobacco Etch Virus (TEV) protease digestion of the protein 
which was then reacted by EPL with the second dye supplied as thioester derivative. The use of TEV 
protease to release an amino-terminal cysteinyl protein was introduced by Tolbert & Wong, who 
demonstrated that TEV protease could accept Cys in the P1 position of its proteolytic site rather than 
the usual Gly [77], enabling the use of TEV recognition site as “protecting group” for the N-terminal 
Cys of a recombinant protein in alternative to the factor Xa recognition site introduced by Muir [67]. 
In another example, Iakovenko and co-workers incorporated a fluorescent probe into a semisynthetic 
version of Rab7, a small GTPase [78]. The fluorophore was incorporated at the C-terminus of the 
protein, a region that is known to be post-translation prenylated by Rab geranylgeranyl transferase 
(RabGGTase). Using this approach, a library of 46 Rab7 analogs conjugated to different fluorophores 
was constructed and the molecules were used as sensors that report on the interaction of Rab7 with 
RabGGTase and the escort protein REP-1 [79]. Recently, we contributed to widen the applications of 
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EPL describing a general method for the incorporation of two molecular probes at different, specific 
positions along the protein framework [80]. The approach is schematically illustrated in Figure 7 and 
combines protein semi-synthesis by EPL with the labeling in solution of a convenient functional group 
(a thiol in our case). 
Figure 7. Schematic procedure to prepare double/triple modified proteins combining EPL 
and chemoselective labeling in solution [80]. 
 
The protein of interest is split in two fragments (N- and C-terminal), possessing a single Cys 
residue. The N-terminal fragment fused to an intein is expressed in E. coli and spliced in presence of 
MESNA, affording the thioester derivative. Then the thioester protein is selectively labeled on its 
unique Cys residue, for example using a probe conjugated with the maleimide. Successively, the 
mono-labeled thioester fragment is reacted with an N-terminal Cys residue by a NCL reaction to afford 
full-length mono-labeled protein. Finally, the Cys residue involved in NCL reaction is exploited to 
introduce the second probe (Figure 7A). Unlike previously reported [81], both labeling reactions are 
performed in solution, enabling the use of mild excess of fluorophores and probes with a chemical 
structure that is not compatible with the harsh conditions of solid phase synthesis. A simpler version of 
our approach can be adopted when the second probe is located at the C-terminus (Figure 7B). In this 
case, the full-length protein containing a single Cys is prepared as thioester derivative and, after the 
first labeling in solution, is reacted with a Cys in an EPL reaction and then labeled with the second 
probe. As proof of concept, we successfully applied our synthetic approach to prepare four fluorescent 
variants of the repeat protein CTPR3 with different probes distances, confirming its efficacy and 
versatility. The protein variants were analyzed by CD and by ensemble-FRET. As the doubly-labeling 
strategy described requires RP-HPLC purification steps, the fluorescent proteins obtained are 
characterized by high purity and homogeneity, thus resulting amenable for single-molecule studies. 
This strategy could be also applied to prepare triple labeled proteins. In fact, the C-terminal fragment 
ending with a Cys residue could be chemically synthesized and selectively labeled on solid phase in a 
specific position. Then, it could be ligated to a labeled protein-thioester fragment to afford a doubly 
labeled species harboring a Cys residue exploitable for the introduction of the third probe (Figure 7C). 
Molecules 2013, 18 450 
 
 
Semi-synthesis of fluorescent proteins can be also accomplished by PTS. Useful strategies have 
been described to tag the N- or C-terminus of a protein of interest with a chemical probe using specific 
split inteins characterized by a splitting site near to one end of the amino acid sequence, allowing for 
the preparation of the shortest domain of the intein by SPPS. For example, an engineered version of the 
Ssp DnaB intein was used by Ludwig et al. [38]. In this case the split site has been shifted at the amino 
acid 11, which is compatible with the chemical synthesis of the IntN fragment and its extein. This 
approach was used to synthesize two fluorescein labeled proteins, the thioredoxin (Trx) and the  
β-lactamase (βLac). For the preparation of fluoresceinated Trx, the IntC domain of Ssp DnaB intein 
(143 aa) was fused to Trx and an His6tag (IntC-Trx-His6). The construct was mixed in equimolar 
amount with a synthetic IntN domain (11 aa) carrying a peptide labeled with a fluorescein as N-extein 
(Fl-extein-IntN). PTS yielded the fluorescent product Fl-Trx-His6 with a reaction rate of about 17 folds 
lower than that reported for Ssp DnaB intein split at previously known site, probably due to the strong 
impact that the new splitting site has on the reassembling and refolding attitude of the Ssp DnaB intein. 
Despite the reduced rate of splicing, the final trans-splicing yield (40–45%) was similar to those 
observed for Ssp DnaB intein split at the canonical site. The use of a higher excess of the synthetic 
domain did not result in an improvement of the final yield. The second protein used as case-of-study, 
βLac, required a refolding step, as the construct IntC-βLac-His6 aggregated in inclusion bodies during 
expression in prokaryotic hosts. Refolding was performed in one step by dialysis and the soluble  
IntC-βLac-His6 was reacted with Fl-extein-IntN, even in this case using equimolar amounts of the two 
reactants. PTS afforded Fl-βLac-His6 with a 35% yield. Both Fl-Trx-His6 and Fl-βLac-His6 were 
subjected to enzymatic activity assays, demonstrating that the semi-synthetic origin of the enzymes did 
not affect their functionality. The utility of the split Ssp DnaB intein has also been improved through 
the selection by a directed evolution approach of a mutant which shows a lower restriction about 
sequences requirements of the flanking exteins and an higher rate of trans-splicing [82]. Furthermore, a 
split variant of the Ssp GyrB intein with the split site near its C-terminus was designed, providing an 
N-terminal intein domain of 150 aa and a C-terminal intein domain of 6 aa only. The use of such intein 
allows for the chemical modification of proteins in the C-terminal region, in a similar fashion to that 
described to label a protein N-terminal region with Ssp DnaB intein. Protein trans-splicing has also 
been exploited to introduce a FRET pair into a single protein [83]. The reported strategy combines PTS 
on recombinant fragments and Cys-labeling in solution. The protein of interest was split at a Ser 
residue in two fragments (ProtN and ProtC), each one bearing a single Cys residue along the amino acid 
sequence. Each fragment was expressed in fusion with a domain of Npu DnaE split intein (IntN and 
IntC) and a solubility enhancing partners. The Ser residue at which the protein of interest has been split 
become placed at the catalytic junction between IntC-ProtC. Usually, inteins prefer a Cys residue at  
this site (however Npu DnaE intein tolerates also this nucleophile) allowing to realize the protein 
doubly-labeling in a three steps scheme. First, IntC-ProtC construct was labeled at Cys with a thiol-reactive 
derivative of the first dye; the presence of a catalytic Ser instead of a Cys ensured to maintain intact the 
nucleophile at this position during Cys labeling. Then, the mono-labeled full protein was obtained 
through PTS by mixing IntC-ProtC and ProtN-IntN. The second dye was finally introduced onto the full 
protein by labeling the only remaining Cys residue. As IntN domain also contains a Cys residue 
involved in the splicing reaction, to preserve intein functionality, the labeling with the second dye was 
performed on the full protein after ligation instead than on the intermediate construct ProtN-IntN. The 
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designed approach was validated through the synthesis of a doubly-labeled di-ubiquitin molecule, in 
which two ubiquitin units are joined by a linker sequence containing a Ser residue. Maltose binding 
protein was selected as enhancer of solubility and purification tag of the construct IntC-Ub while  
Ub-IntN was expressed in fusion with a His6tag. Each unit of Ub bore a single Cys residue introduced 
by mutagenesis respectively at position 47 and 7. These sites were selected as they are exposed outside 
the Ub hydrophobic core. The doubly-labeled construct obtained was used to study the unfolding 
process by FRET. Recently, Muir’s group performed a systematic study of 18 cyanobacterial split 
DnaE inteins and several of them resulted to be “ultrafast” inteins, able to catalyze protein trans-splicing 
in tens of seconds, as previously observed for the Npu DnaE intein [84]. They analyzed the effect 
caused by C-extein sequence variation on ultrafast inteins trans-splicing rate, observing different 
degree of tolerance for each intein and kind of mutation. The ultrafast inteins appear an attractive and 
efficient tool to prepare α-thioester proteins for EPL [85]. 
The general applicability of PTS approach is however limited by the instability of the split protein 
fragments which can aggregate in inclusion bodies and for whom refolding procedures are not always 
successful. Besides, many inteins are not completely promiscuous regarding their exteins, showing often 
strong restrictions on the sequences that they tolerate in the proximity of the junction site extein-intein, 
limiting the number of protein targets that can be prepared by PTS. 
2.2. Protein Labeling with Fluorescent Probes for Fluorescence Microscopy in Living Cells 
The ability to track the position and the movements of proteins inside a living cell is a key approach 
to describe cellular mechanisms and protein functions. In the last years, we assisted to an explosion of 
chemical biology tools to label proteins for microscopy applications. Beck-Sickinger and coworkers 
described the site-specific fluorescent modification by EPL of the SDF1α chemokine. SDF1α (1–49) 
fragment was expressed as Mxe GyrA intein-fusion protein. Fusion protein was purified on chitin 
resin, exploiting the presence of the CBD at the intein C-terminus; thioester SDF1α (1–49) was 
obtained on resin after incubation with MESNA. The SDF1α (50–68) C-terminal peptide, starting with 
a native Cys, was synthesized by SPPS and labeled on solid phase with carboxyfluorescein at the  
C-terminal Lys residue. It was selected for labeling as it was assumed it did not interfere with the 
correct protein folding. EPL between the two fragments lasted 24 h. Since SDF1α contains two 
disulfide bridges, after ligation the full product was refolded and oxidized using the cysteine/cystine 
redox system. The well folded product was purified by HPLC, as the retention time of the oxidized 
species shifted with respect to the linear compound. Fluorescence microscopy studies carried out on 
the labeled chemokine demonstrated that the semi-synthetic SDF1α is biologically functional 
molecule, able to induce chemotaxis and to be internalized upon specific binding to its receptor 
CXCR4, supporting the extension of such synthetic protocol to other chemokine and to the introduction 
of other modifications [86]. EPL has also been harnessed to control the activity of a post-translational 
modified protein inside living cells by the use of photocleavable caging groups. In this approach, EPL 
is used to synthesize the protein of interest modified with a fluorophore and a caging group which 
quenches the fluorophore and, contemporary, suppresses the protein activity. The caging group is 
photocleavable and thus it can be removed upon light exposure ensuring to switch on protein activity 
and dye fluorescence emission. For example, this strategy was applied to the protein Smad2, involved 
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in the transforming growth factor α (TGF-α) signaling pathway. The activation of Smad2 requires 
phosphorylation of two Ser residues placed at protein C-terminus. In the phopshorylated Smad2, the  
C-terminal carboxylate stabilizes a homotrimeric structure. The presence of a caging moiety at the  
C-terminus, able to disrupt the homotrimeric interactions, maintains the phosphorylated protein in an 
inactive state. UV irradiation induces the cleavage of the caging group and restores Smad2 activity. 
Smad2 analog harboring two phospho-Ser residues, a fluorescein as fluorescent probe, a dabcyl as 
quencher and the 4-[4-(1-hydroxyethyl)-2-methoxy-5-nitrophenoxy]butanoic acid as photo-cleavable 
caging group was prepared by semi-synthesis. Thioester Smad2 lacking the last five residues was 
prepared by intein-fusion technology, complexed with the membrane-anchored protein SARA and 
reacted with a synthetic peptide containing all the functional groups listed before [87]. In a subsequent 
work, the same concept and semi-synthetic strategy was applied to prepare caged phosphorylated and 
unphosphorylated Smad2, containing respectively the green fluorophore carboxyfluorescein and the 
red fluorophore tramethylrhodamine. Fluorescence appeared to be titratable by modulating the extent 
of UV-light exposition. The two proteins were co-injected into live cells and their fluorescence before 
and after photoactivation was monitored. This strategy enabled to track the phosphorylated and 
nonphosphorylated Smad2 inside the same single-living cell [88]. A C-terminal protein labeling was 
described by Chaisemartin et al. using a Cys analog linked to a N-1' fluorescent biotinyl derivative; the 
molecule was used to induce splicing of the fusion construct consisting of the intein Mxe GyrA and a 
scFv directed against the GTPase RhoB. Splicing afforded the fluorescent scFv which was purified to 
homogeneity exploiting the biotin hand [89], while fluorescent probe allowed the in vivo antibody 
detection. A “mirror” approach, useful to label protein N-terminus, has also been described and applied 
to the imaging in living cells [3]. In this work, the intein-mediated protein splicing allowed the in vivo 
generation of the target protein bearing an N-terminal Cys residue. EPL with membrane-permeant 
thioester-containing fluorophore allowed site-specific labeling of the protein. Other examples of  
N-terminal Cys containing proteins labeling with thioester molecules were also reported [90–92]. 
Protein labeling can be also accomplished in vivo by using protein trans-splicing, as firstly described 
by Giriat and Muir [93]. To validate their semi-synthetic approach, GFP was expressed in cells as 
fusion protein with the N-terminal fragment of Ssp DnaE split intein. The C-terminal Ssp DnaE intein 
fragment was instead fused to the FLAG epitope and supplied to the cell media. The latter construct 
was able to penetrate through cell wall thanks to a Protein Transduction Domain (PTD) peptide which 
served as a signal peptide and which was ligated to IntC-FLAG through a disulfide bridge. Western-blot 
analysis of the cell lysate with anti-GFP and anti-FLAG antibodies demonstrated the ability of the 
intein to reconstitute in vivo and splice giving the GFP-FLAG as product. The naturally occurring split 
intein Npu DnaE, characterized by the highest rate of trans-splicing reaction, has also been adopted to 
ligate an exogenous polypeptide to a membrane protein exposed by living cells, offering a useful way 
to modify a cell surface protein. The 36 amino acids C-terminal domain of the Npu DnaE intein (IntC) 
was expressed in eukaryotic cells as fusion with a transmembrane domain derived from PDGF receptor 
(TM), a soluble partner (Trx) and the fluorescent protein mCherry. Microscopy analysis on living cells 
showed that the construct IntC-Trx-TM-mCherry was localized on plasma membrane. Cells were 
incubated with a green fluorescent protein carrying the complementary moiety of the Npu DnaE intein 
(102 amino acids), the construct eGFP-IntN, which was expressed in E. coli and purified. Specific  
co-localization of mCherry and eGFP proteins at cell surface was verified by confocal microscopy, 
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demonstrating that Npu DnaE intein was able to reconstitute into a functional splicing unit in a cellular 
context. Npu DnaE intein has two catalytic cysteines involved in PTS reaction that must be reduced to 
ensure successful trans-splicing. Authors observed that PTS was not compromised if the contruct 
eGFP-IntN was preincubated with DTT and dyalized against PBS before the incubation with cells. 
Direct incubation of cells with DTT should be avoided as thiols may damage cell membranes. The 
semi-synthetic approach was extended to the preparation of proteins attached to the membrane through 
a glycosylphosphatidylinositol (GPI) anchor. To this scope, the IntC domain was expressed endogenously 
in fusion with the GPI signaling sequence Gas1p, which triggers its attachment to a glycolipid anchor 
on the cell membrane. Incubation with eGFP-IntN allowed membrane labeling through a GPI-anchor [94]. 
3. Isotopic Labeling 
Structural characterization by NMR spectroscopy may be not trivial if applied to large proteins, due 
to significant loss of spectral resolution and chemical shifts overlap. Both effects are progressively 
amplified as the protein size increases, hampering unambiguous signals assignment. The synthesis of 
large proteins by ligation methods, such as EPL, may resolve this issue. Through a synthetic approach, 
named segmental isotopic labeling, a selected portion of a protein, such as a single protein domain or 
region, can be specifically labeled with 13C, 15N and/or 2H isotopes and analyzed by NMR 
spectroscopy in the context of the native full protein (Figure 8). Segmental labeling allows to reduce 
the complexity of the NMR spectrum as only the signals of the labeled region are revealed, facilitating 
the structural analysis of the labeled protein portion. 
Figure 8. Semi-synthetic strategy for isotope labeling of an internal protein domain. The 
labeled protein domain is reported in yellow. PG is a protease recognition site which 
releases a N-terminal cysteinyl-protein. 
 
Muir’s group reported the first example of segmental labeling by EPL [95,96]. In this work, EPL 
was used to prepare the Abelson protein tyrosine kinase-SH(3,2) domain pair, in which only one of the 
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two domains was labeled with 15N. Unlabeled Abl-SH3 domain was prepared as C-terminal ethyl 
thioester using intein technology and reacted with N-terminal Cys containing (15N)Abl-SH2. A 
combination of mass spectrometry and NMR spectroscopy techniques was used to confirm the identity 
and the correct structure of the ligation product, which also showed the appropriate ligand-binding 
properties. The same semi-synthetic procedure was adopted by Camarero et al. to isotopically label the 
C-terminal region of a sigma70-like subunit from Thermotoga maritima in order to study the 
mechanism of autoinhibition mediated by its own N-terminal 90 amino acids by NMR [97]. More 
recently, the Gierasch’s group described the segmental isotopic labeling of the E. coli Hsp70 molecular 
chaperone DnaK [98]. One of its two constituent domains, the ATPase domain, was expressed as  
N-terminal fusion with the Mxe GyrA intein in minimal medium containing 2H, 13C and 15N isotopes 
sources, generating a labeled C-terminal thioester derivative after incubation with the thiol MESNA. 
The complementary substrate-binding domain (SBD) was expressed as C-terminal fusion with Ssp 
DnaB intein to generate, after intein splicing, a N-terminal Cys residue. The two domains were then 
ligated, affording full DnaK bearing the ATPase domain labeled with NMR active isotopes. In order to 
optimize ligation yield, many conditions were tested, evaluating the effects of varying pH, temperature, 
reagents concentration and ratio, denaturant concentration. Interestingly, they found appropriate to 
carry out the ligation reaction at low urea concentration (2 M) to enhance ligation efficiency, while 
higher or lower denaturant concentration resulted in a decreased ligation yield. They interpreted these 
results hypothesizing that urea concentrations higher than 2 M disrupt specific domain-domain 
interactions which bring together the ligands and promote ligation. At lower urea concentrations, instead, 
domains interaction persists but ligation yield falls down due to poor accessibility of C-terminal 
thioester group and N-Cys of the two domains. The former effect does not affect ligation yield if the 
reaction is carried out using millimolar reagent concentrations and an excess of SBD domain. 
Vitali et al. described an interesting segmental labeling reaction performed on resin, which requires 
the concerted use of two inteins, the Mxe GyrA and Ssp DnaB inteins. The synthetic procedure was 
adopted to prepare and characterize by NMR a series of segmentally labeled variants of the RNA 
recognition motifs (RRM3 and RRM4) of the polypyrimidine tract binding protein (PTB). The RRM3 
motif was expressed in fusion with Mxe GyrA intein and a CBD as affinity partner, while RRM4 was 
fused at the C-terminus of the Ssp DnaB intein and at the N-terminus to a CBD. As both fusion 
proteins bore the same affinity tag, they were co-loaded onto a chitin resin and the splicing of each 
intein was induced. Firstly, Mxe GyrA intein was spliced upon incubation with MESNA, releasing a  
C-terminal α-thioester RRM3. Then, a temperature switch to 37 °C allowed Ssp DnaB intein splicing, 
leaving RRM4 domain with an amino-terminal Cys residue. Once released, the two domains promptly 
reacted, affording a unique polypeptide chain. The full-length product was finally purified on Ni2+-resin, 
exploiting the His6 tag placed upstream RRM3 as additional affinity moiety. The ability of the two 
domains to interact facilitated their successful ligation. Segmental labeling could simply be accomplished 
loading onto the chitin resin an isotopically labeled RRM-Intein-CBD construct. By the use of the 
described on column procedure, many segmentally-labeled variants of RRM34 were prepared carrying 
15N,13C-labeled RRM3 and an unlabeled RRM4, unlabeled RRM3 and a 15N,13C-labeled RRM4 and a 
15N,13C-labeled RRM3 and a 15N-only-labeled RRM4 [99]. The same procedure was adopted and 
improved by Skrisovska and Allain, who described the characterization of two different multidomain 
proteins containing RNA recognition motifs (RRMs), heterogeneous nuclear ribonucleoprotein L and 
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Npl3p. In this work, the splicing-ligation on column procedure was extended to insoluble protein, 
adding a refolding step before protein binding on resin, and to non-interacting domains, for which  
full-length protein yield was enhanced by eluting from the resin and concentrating the non-ligated 
reactants. The proteins were obtained in high yields, allowing to characterize their interdomain 
interactions by NMR spectroscopy [100]. An elegant approach was also proposed by Zhao et al. that 
reported an efficient on-column EPL strategy for the semi-synthesis of human apolipoprotein E (apoE) 
triply-labeled with 2H, 15N and 13C. The protein was expressed in two fragments. The N-terminal 
portion of ApoE was expressed as intein fusion construct and also bore a CBD as affinity tag. After 
binding on a chitin-resin, the fusion protein was incubated with the C-terminal ApoE fragment, also 
prepared by recombinant means and harboring a N-terminal Cys, to perform on-resin ligation reaction. 
Using this on-column ligation approach, once generated from intein thiolysis, the thioester species may 
readily react with the N-terminal Cys-fragment, strongly reducing the probability of hydrolysis of the 
thioester group and increasing the ligation yield. By this protocol, several variants of ApoE were 
prepared combining the two fragments labeled with three different NMR active nuclei, 2H, 15N or  
13C [101,102]. Another biological problem which was addressed by segmental labeling is the study of 
ubiquitin biology. The attachment of a ubiquitin (Ub) or of poly-Ub to a target protein may regulate a 
great number of cellular processes, such as protein proteasomal degradation, transcriptional activation, 
vesicular trafficking of proteins. Poly-Ub chains are made by linking to each other Ub monomers 
through an isopeptide bond between the -amino group of one of the seven Lys residues of a monomer 
with the C-terminus of the next one or head-to-tail. Depending on the Lys involved into poly-Ub 
assembling, poly-Ub chains may work as molecular signals for different biological processes. 
Probably, the specificity of each poly-Ub chains depends on the different conformation that each one 
assumes depending on the sites of ramification. The characterization of the interaction of different 
poly-Ub with their receptors requires the ability to prepare homogeneous preparation of poly-Ub with 
a defined linkage between each Ub monomer. EPL fulfills such request, being more selective and 
versatile than enzymatic methods. However, due to its homo-polymeric nature, NMR studies of  
poly-Ub chains represent a challenging task. Segmental labeling offers a solution to the problem, 
allowing to observe each single Ub monomer in the context of the branched poly-Ub. Castaneda et al. 
reported the semi-synthesis of a segmentally isotopic labeled Ub2 chains. A Ub monomer carrying a  
-mercaptolysine at two positions (33 or 48) was prepared by chemical synthesis and reacted with a  
C-terminal thioester (15N)-labeled Ub monomer, obtained by recombinant expression as intein fusion 
protein. EPL allowed the formation of an isopeptide bond between the two monomers. After ligation, 
the thiol group in -position of the Lys was removed by desulfurization, affording a native- like di-Ub 
molecule [103]. The variant in which the two Ub monomers are linked through Lys48 was used as 
control construct, as this poly-Ub has been widely characterized by NMR. Data obtained using the 
segmentally labeled synthetic K48-linked di-Ub demonstrated that it is structurally identical to the one 
assembled using enzyme, confirming that the protein chains obtained by EPL are ‘‘native-like’’ and 
paving the way to the structural, conformational and ligand-binding properties characterization by 
NMR of the K33-linked di-Ub variant. EPL is a useful approach even for the site-specific introduction 
of one or few stable isotopes within a protein. Romanelli et al. applied the segmental isotopic labeling 
to selectively dual label the scissile peptide bond at the N-extein/intein junction of Mxe GyrA intein 
with 13C and 15N nuclei. 15N uniformly labeled Mxe GyrA intein was ligated to a synthetic pentapeptide 
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labeled with 13C only on the C-terminal carboxylic group (Figure 9). On such construct they were able 
to measure the amide 1JNC’ coupling constant which was found to be of 12.3 Hz. This result suggests that 
this amide bond is unusually polarized, because of non-planarity, allowing one to explain the extreme 
lability of the N-extein-intein bond which is broken in the first step of protein splicing. Additional 
studies demonstrated that a conserved His residue of intein block B is absolutely required to catalyze 
the first step of the splicing reaction and contributes to maintain the (-1) scissile bond in its unusual 
conformation [104]. Further investigations on Mxe GyrA intein splicing mechanism were carried out 
performing NMR studies on a semi-synthetic branched intermediate prepared ligating a recombinant 
1–184 α-thioester intein fragment with a synthetic branched peptide reproducing the intein remaining 
portion (aa 185–198) with the C-extein and carrying the N-extein attached to the side chain of a  
Thr. Furthermore, the 13C and 15N isotopes were specifically incorporated into the scissile +1 peptide  
bond [105]. In another example, a series of 13C-labeled amino acids were incorporated at the C-terminus 
of the α-subunit of a heterotrimeric G protein [106]. Using EPL, 9-mer peptides containing 13C labels 
in Leu-348 (uniform), Gly-352 (alpha carbon), and Phe-354 (ring) were ligated to recombinant Gα 
subunit lacking the corresponding carboxyl-terminal residues. Analysis of the 13C resonances indicated 
that the C-terminus of the Gα subunit is unstructured when the protein is bound to GDP, but adopts an 
ordered conformation upon activation by AlF4−. 
Figure 9. Semi-synthesis of Mxe GyrA intein with the scissile (-1) peptide bond dual 
labeled with 13C and 15N. Mxe GyrA intein (green) was uniformely labeled with 15N. Extein 
peptide (yellow) was synthesized by SPPS with a 13C α-carboxylate. 
 
EPL allows even for the segmental labeling of a protein internal region. To this purpose EPL makes 
use of sequential-ligation tools, as firstly described by Muir’s group who semi-synthesized the  
304 amino acids Crk-II protein through the sequential assembling of three recombinant polypeptides. 
In such approach, the central segment bears both a C-terminal thioester and a “cryptic” N-terminal Cys 
masked by a protease cleavage site which prevents the self-reaction of the central polypeptide. After 
EPL between the central thioester segment and the C-terminal polypeptide, protease cleavage allows to 
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reveal the α-Cys in the intermediate protein. Reaction with N-terminal segment, harboring the C-terminal 
thioester function, may afford the full protein [107]. Zaragöz et al. applied EPL to the semi-synthesis 
of the dimeric protein Hsp90, evaluating the effect on ligation yield of varying critic parameters such 
as reactants concentration, pH, ligation site. They developed an EPL based protocol suitable for the 
preparation of segmentally labeled dimeric proteins [108]. Another application of segmental labeling 
refers to infrared spectroscopy. Moran et al. applied segmental labeling to the study of human  
γD-crystallin amyloid fibrils by two-dimensional IR spectroscopy. EPL was used to uniformly label 
with 13C one of the two Greek key domains in order to individually resolve them in (2D) IR spectra of 
acid-induced amyloid fibrils [109,110]. Segmental labeling can also be accomplished by intein  
trans-splicing. This approach has been, recently, exploited by the Iwai’s group which described a 
strategy to label an internal region of a protein of interest using the split intein Npu DnaE [111] and 
more recently the preparation of a segmentally labeled version of the multi-domain CheA protein from 
E. coli both by EPL and trans-splicing [112]. In the latter work, pTWIN vector was used to express the 
two domains of the 140 kDa protein CheA respectively as Mxe GyrA and Ssp DnaB fusion constructs. 
EPL between the two domains was performed in native conditions and thus gave a ligation yield of 
only 10%–40% due to the impossibility to reach high reactant concentrations under non-denaturing 
conditions. PTS performed using Npu DnaE intein gave better results because the trans-splicing 
reaction does not require high reactant concentrations as the two intein fragments show a very high 
affinity. Intein trans-splicing mediated segmental labeling was also applied to study F1-ATPase, whose 
characterization by NMR is hampered by its amino acid length. A segmental labeling procedure based 
on the use of PI-pfuI intein was applied to label the β subunit of the protein and allowed to successfully 
assign the great majority of signals of the beta subunit monomer. The structures elaborated from the 
collected NMR data suggested that the subunit beta monomer assumes the open form in the absence of 
the nucleotide, while nucleotide binding induces a conformational change from the open to the closed 
form. The structural change of the beta subunit monomer induced by nucleotide binding triggers the 
rotation of F1-ATPase [113]. In a subsequent work, the segmentally labeled F1-ATPase was studied to 
gain deeper insights into the rotation of F1-ATPase, driven by the open/close bending motion of the β 
subunit [114]. An interesting approach has been described by the Iwai’s group to segmentally label a 
protein by in vivo PTS [115–117]. In this synthetic scheme the two protein fragments of a target 
protein are expressed in fusion with the N or C domain of a split intein. Each fusion construct is placed 
under the control of an inducible promoter, for instance the T7 and arabinose promoters respectively 
inducible by IPTG and arabinose. Bacterial cells co-transformed with both the recombinant plasmids 
are cultured and subjected to two sequential induction steps. First, labeled domain expression is 
induced in minimal medium containing isotopes source; then, cells are harvested by centrifugation, 
resuspended in rich culture medium and then expression of the complementary domain is induced.  
In vivo PTS affords segmentally labeled full-length protein target. Such approach has been used by 
Iwai’s group to prepare a 15N-segmentally labeled variant of the c-CRKII adaptor domain using the 
split intein Npu Dna E [115]. Segmental labeling by PTS has also been adopted to overcome the 
solubility limit of a protein sample for NMR studies. In fact, a common obstacle to NMR studies of 
proteins is the preparation of samples in soluble form at high concentration, usually in the millimolar 
range. To improve protein solubility, fusion of the target protein to a solubility enhancement tag 
(SET), such as the glutathione S-transferase, the maltose-binding protein or the thioredoxin, allows one 
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to overcome the problem and at the same time facilitates the purification procedures. However, many 
extra signals arise from the SET, complicating the NMR spectrum. Segmental isotopic labeling offers 
the right solution to the quest trough the so called “invisible SET’’ approach, referring to the 
preparation of a SET fusion protein in which solely the target protein is isotopes enriched. Using in 
vivo intein trans-splicing, the non-isotope labeled SET protein GB1 (Streptococcus Protein G B1 
domain) was fused to 15N-labeled chitin binding domain (CBD), improving its solubility for a study by 
solution NMR spectroscopy [117]. Although of great originality, the shortcoming of such approach is 
that the target protein does not possess a stabilizing fusion partner during expression and thus it may 
aggregate into inclusion bodies before in vivo ligation, becoming unable to react with the SET. In order 
to overcome such limitation, Kobayashi et al. developed an alternative invisible SET approach, always 
based on intein trans-splicing mechanism. The target protein, the ribosome binding factor A (RbfA), 
was expressed in isotopes enriched medium as fusion construct with a tandem repeated N-terminal 
domains of the protein S from Myxococcus xanthus, previously reported to be a useful SET [118], and 
with the C-terminal domain of a split intein. The same SET protein was expressed fused to the split N-
terminal domain of the intein. Intein trans-splicing between them allowed to swap the labeled SET 
from RbfA with an unlabeled one. Using this approach, RbfA soluble expression is ensured by fusion 
with protein S tag even during expression phase and NMR characterization is facilitated by 
suppressing SET signal trough segmental labeling [119]. 
4. Conclusions 
Protein semi-synthesis by EPL is nowadays a mature technology, it has demonstrated its utility to 
solve numerous scientific issues, especially in chemical biology and biophysics. In particular, EPL is 
one of the favorite methods to prepare high pure and homogenous proteins modified with specific 
probes, as fluorescent dyes or isotopes. This aim is achieved developing several ingenious synthetic 
strategies, indicative of the flexibility of EPL technology. In fact, EPL combines the advantages of 
organic chemistry with the easy and size limitless of recombinant protein expression, enabling a single 
protein to be functionalized at one or even more specific positions with different probes irrespective of 
its size. In definitive, EPL is an excellent strategy for the chemical synthesis of labeled protein which 
can find application in wide variety of life-science laboratories. 
References 
1. Stephanopoulos, N.; Francis, M.B. Choosing an effective protein bioconjugation strategy.  
Nat. Chem. Biol. 2011, 7, 876–884. 
2. Basle, E.; Joubert, N.; Pucheault, M. Protein chemical modification on endogenous amino acids. 
Chem. Biol. 2010, 17, 213–227. 
3. Chattopadhaya, S.; Abu Bakar, F.B.; Yao, S.Q. Use of intein-mediated protein ligation strategies 
for the fabrication of functional protein arrays. Meth. Enzymol. 2009, 462, 195–223. 
4. Hinner, M.J.; Johnsson, K. How to obtain labeled proteins and what to do with them. Curr. Opin. 
Biotechnol. 2010, 21, 766–776. 
5. Kent, S.B. Total chemical synthesis of proteins. Chem. Soc. Rev. 2009, 38, 338–351. 
Molecules 2013, 18 459 
 
 
6. Muralidharan, V.; Muir, T.W. Protein ligation: An enabling technology for the biophysical 
analysis of proteins. Nat. Methods 2006, 3, 429–438. 
7. Merrifield, B.R. Solid Phase Peptide Synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 
1963, 85, 2149–2154. 
8. Schnolzer, M.; Kent, S.B. Constructing proteins by dovetailing unprotected synthetic peptides: 
Backbone-engineered HIV protease. Science 1992, 256, 221–225. 
9. Liu, C.F.; Tam, J.P. Peptide segment ligation strategy without use of protecting groups. Proc. 
Natl. Acad. Sci. USA 1994, 91, 6584–6588. 
10. Liu, C.F.; Tam, J.P. Chemical ligation approach to form a peptide bond between unprotected 
peptide segments. Concept and model study. J. Am. Chem. Soc. 1994, 116, 4149–4153. 
11. Robey, F.A.; Fields, R.L. Automated synthesis of N-bromoacetyl-modified peptides for the 
preparation of synthetic peptide polymers, peptide-protein conjugates, and cyclic peptides.  
Anal. Biochem. 1989, 177, 373–377. 
12. Smyth, D.G.; Blumenfeld, O.O.; Konigsberg, W. Reactions of N-Ethylmaleimide with Peptides 
and Amino Acids. Biochem. J. 1964, 91, 589–595. 
13. Rostovtsev, V.V.; Green, L.G.; Fokin, V.V.; Sharpless, K.B. A stepwise huisgen cycloaddition 
process: Copper(I)-catalyzed regioselective “ligation” of azides and terminal alkynes.  
Angew. Chem. Int. Ed. Engl. 2002, 41, 2596–2599. 
14. Tornoe, C.W.; Christensen, C.; Meldal, M. Peptidotriazoles on solid phase: [1,2,3]-Triazoles by 
regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides.  
J. Org. Chem. 2002, 67, 3057–3064. 
15. De Araujo, A.D.; Palomo, J.M.; Cramer, J.; Seitz, O.; Alexandrov, K.; Waldmann, H. Diels-Alder 
ligation of peptides and proteins. Chem. Eur. J. 2006, 12, 6095–6109. 
16. Dawson, P.E.; Kent, S.B. Synthesis of native proteins by chemical ligation. Annu. Rev. Biochem. 
2000, 69, 923–960. 
17. Dirksen, A.; Dawson, P.E. Expanding the scope of chemoselective peptide ligations in chemical 
biology. Curr. Opin. Chem. Biol. 2008, 12, 760–766. 
18. Dawson, P.E.; Muir, T.W.; Clark-Lewis, I.; Kent, S.B. Synthesis of proteins by native chemical 
ligation. Science 1994, 266, 776–779. 
19. Nilsson, B.L.; Kiessling, L.L.; Raines, R.T. Staudinger ligation: A peptide from a thioester and 
azide. Org. Lett. 2000, 2, 1939–1941. 
20. Muir, T.W. Semisynthesis of proteins by expressed protein ligation. Annu. Rev. Biochem. 2003, 
72, 249–289. 
21. Muir, T.W.; Sondhi, D.; Cole, P.A. Expressed protein ligation: A general method for protein 
engineering. Proc. Natl. Acad. Sci. USA 1998, 95, 6705–6710. 
22. Xu, M.Q.; Perler, F.B. The mechanism of protein splicing and its modulation by mutation. 
EMBO J. 1996, 15, 5146–5153. 
23. Flavell, R.R.; Muir, T.W. Expressed protein ligation (EPL) in the study of signal transduction, 
ion conduction, and chromatin biology. Acc. Chem. Res. 2009, 42, 107–116. 
24. Cowburn, D.; Muir, T.W. Segmental isotopic labeling using expressed protein ligation.  
Meth. Enzymol. 2001, 339, 41–54. 
Molecules 2013, 18 460 
 
 
25. Ziaco, B.; Pensato, S.; D’Andrea, L.D.; Benedetti, E.; Romanelli, A. Semisynthesis of dimeric 
proteins by expressed protein ligation. Org. Lett. 2008, 10, 1955–1958. 
26. Xiao, J.; Hamilton, B.S.; Tolbert, T.J. Synthesis of N-terminally linked protein and peptide 
dimers by native chemical ligation. Bioconjug. Chem. 2010, 21, 1943–1947. 
27. Southworth, M.W.; Amaya, K.; Evans, T.C.; Xu, M.Q.; Perler, F.B. Purification of proteins 
fused to either the amino or carboxy terminus of the Mycobacterium xenopi gyrase A intein. 
Biotechniques 1999, 27, 110–114,116,118–120. 
28. Telenti, A.; Southworth, M.; Alcaide, F.; Daugelat, S.; Jacobs, W.R., Jr.; Perler, F.B. The 
Mycobacterium xenopi GyrA protein splicing element: Characterization of a minimal intein.  
J. Bacteriol. 1997, 179, 6378–6382. 
29. Valiyaveetil, F.I.; MacKinnon, R.; Muir, T.W. Semisynthesis and folding of the potassium 
channel KcsA. J. Am. Chem. Soc. 2002, 124, 9113–9120. 
30. Johnson, E.C.; Kent, S.B. Insights into the mechanism and catalysis of the native chemical 
ligation reaction. J. Am. Chem. Soc. 2006, 128, 6640–6646. 
31. Mathys, S.; Evans, T.C.; Chute, I.C.; Wu, H.; Chong, S.; Benner, J.; Liu, X.Q.; Xu, M.Q. 
Characterization of a self-splicing mini-intein and its conversion into autocatalytic N- and  
C-terminal cleavage elements: Facile production of protein building blocks for protein ligation. 
Gene 1999, 231, 1–13. 
32. Sun, Z.; Chen, J.; Yao, H.; Liu, L.; Wang, J.; Zhang, J.; Liu, J.N. Use of Ssp dnaB derived  
mini-intein as a fusion partner for production of recombinant human brain natriuretic peptide in 
Escherichia coli. Protein Expr. Purif. 2005, 43, 26–32. 
33. Esipov, R.S.; Stepanenko, V.N.; Chupova, L.A.; Boyarskikh, U.A.; Filipenko, M.L.; 
Miroshnikov, A.I. Production of recombinant human epidermal growth factor using Ssp dnaB 
mini-intein system. Protein Expr. Purif. 2008, 61, 1–6. 
34. Yan, S.S.; Yan, J.; Shi, G.; Xu, Q.; Chen, S.C.; Tian, Y.W. Production of native protein by using 
Synechocystis sp. PCC6803 DnaB mini-intein in Escherichia coli. Protein Expr. Purif. 2005, 40, 
340–345. 
35. Wu, H.; Hu, Z.; Liu, X.Q. Protein trans-splicing by a split intein encoded in a split DnaE gene of 
Synechocystis sp. PCC6803. Proc. Natl. Acad. Sci. USA 1998, 95, 9226–9231. 
36. Appleby, J.H.; Zhou, K.; Volkmann, G.; Liu, X.Q. Novel split intein for trans-splicing synthetic 
peptide onto C terminus of protein. J. Biol. Chem. 2009, 284, 6194–6199. 
37. Aranko, A.S.; Zuger, S.; Buchinger, E.; Iwai, H. In vivo and in vitro protein ligation by naturally 
occurring and engineered split DnaE inteins. PLoS One 2009, 4, e5185. 
38. Ludwig, C.; Pfeiff, M.; Linne, U.; Mootz, H.D. Ligation of a synthetic peptide to the N terminus 
of a recombinant protein using semisynthetic protein trans-splicing. Angew. Chem. Int. Ed. Engl. 
2006, 45, 5218–5221. 
39. Sun, W.; Yang, J.; Liu, X.Q. Synthetic two-piece and three-piece split inteins for protein  
trans-splicing. J. Biol. Chem. 2004, 279, 35281–35286. 
40. Lippincott-Schwartz, J.; Patterson, G.H. Development and use of fluorescent protein markers in 
living cells. Science 2003, 300, 87–91. 
41. Tsien, R.Y. The green fluorescent protein. Annu. Rev. Biochem. 1998, 67, 509–544. 
Molecules 2013, 18 461 
 
 
42. Shaner, N.C.; Steinbach, P.A.; Tsien, R.Y. A guide to choosing fluorescent proteins. Nat. Methods 
2005, 2, 905–909. 
43. Tsien, R.Y. Imagining imaging’s future. Nat. Rev. Mol. Cell Biol. 2003, 4, SS16–SS21. 
44. Zhang, J.; Campbell, R.E.; Ting, A.Y.; Tsien, R.Y. Creating new fluorescent probes for cell 
biology. Nat. Rev. Mol. Cell Biol. 2002, 3, 906–918. 
45. Yeo, D.S.; Srinivasan, R.; Chen, G.Y.; Yao, S.Q. Expanded utility of the reaction. Chem. Eur. J. 
2004, 10, 4664–4672. 
46. Chen, I.; Ting, A.Y. Site-specific labeling of proteins with small molecules in live cells.  
Curr. Opin. Biotechnol. 2005, 16, 35–40. 
47. Hermanson, G.T. Bioconjugate Techniques; Academic Press: San Diego, CA, USA, 1996. 
48. Smith, M.E.; Schumacher, F.F.; Ryan, C.P.; Tedaldi, L.M.; Papaioannou, D.; Waksman, G.; 
Caddick, S.; Baker, J.R. Protein modification, bioconjugation, and disulfide bridging using 
bromomaleimides. J. Am. Chem. Soc. 2010, 132, 1960–1965. 
49. Kao, M.W.; Yang, L.L.; Lin, J.C.; Lim, T.S.; Fann, W.; Chen, R.P. Strategy for efficient  
site-specific FRET-dye labeling of ubiquitin. Bioconjug. Chem. 2008, 19, 1124–1126. 
50. Smith, J.J.; Conrad, D.W.; Cuneo, M.J.; Hellinga, H.W. Orthogonal site-specific protein 
modification by engineering reversible thiol protection mechanisms. Protein Sci. 2005, 14, 64–73. 
51. Griffin, B.A.; Adams, S.R.; Tsien, R.Y. Specific covalent labeling of recombinant protein 
molecules inside live cells. Science 1998, 281, 269–272. 
52. Adams, S.R.; Campbell, R.E.; Gross, L.A.; Martin, B.R.; Walkup, G.K.; Yao, Y.; Llopis, J.; 
Tsien, R.Y. New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and  
in vivo: Synthesis and biological applications. J. Am. Chem. Soc. 2002, 124, 6063–6076. 
53. Cao, H.; Chen, B.; Squier, T.C.; Mayer, M.U. CrAsH: A biarsenical multi-use affinity probe with 
low non-specific fluorescence. Chem. Commun. (Camb) 2006, 2006, 2601–2603. 
54. Halo, T.L.; Appelbaum, J.; Hobert, E.M.; Balkin, D.M.; Schepartz, A. Selective recognition of 
protein tetraserine motifs with a cell-permeable, pro-fluorescent bis-boronic acid. J. Am. Chem. Soc. 
2009, 131, 438–439. 
55. Uchinomiya, S.H.; Nonaka, H.; Fujishima, S.H.; Tsukiji, S.; Ojida, A.; Hamachi, I. Site-specific 
covalent labeling of His-tag fused proteins with a reactive Ni(II)-NTA probe. Chem. Commun. 
(Camb) 2009, 2009, 5880–5882. 
56. Strunk, J.J.; Gregor, I.; Becker, Y.; Lamken, P.; Lata, S.; Reichel, A.; Enderlein, J.; Piehler, J. 
Probing protein conformations by in situ non-covalent fluorescence labeling. Bioconjug. Chem. 
2009, 20, 41–46. 
57. Ojida, A.; Honda, K.; Shinmi, D.; Kiyonaka, S.; Mori, Y.; Hamachi, I. Oligo-Asp tag/Zn(II) 
complex probe as a new pair for labeling and fluorescence imaging of proteins. J. Am. Chem. Soc. 
2006, 128, 10452–10459. 
58. Keppler, A.; Gendreizig, S.; Gronemeyer, T.; Pick, H.; Vogel, H.; Johnsson, K. A general 
method for the covalent labeling of fusion proteins with small molecules in vivo. Nat. Biotechnol. 
2003, 21, 86–89. 
59. Gautier, A.; Juillerat, A.; Heinis, C.; Correa, I.R., Jr.; Kindermann, M.; Beaufils, F.; Johnsson, K. 
An engineered protein tag for multiprotein labeling in living cells. Chem. Biol. 2008, 15, 128–136. 
Molecules 2013, 18 462 
 
 
60. Los, G.V.; Encell, L.P.; McDougall, M.G.; Hartzell, D.D.; Karassina, N.; Zimprich, C.; Wood, M.G.; 
Learish, R.; Ohana, R.F.; Urh, M.; et al. HaloTag: A novel protein labeling technology for cell 
imaging and protein analysis. ACS Chem. Biol. 2008, 3, 373–382. 
61. Antos, J.M.; Chew, G.L.; Guimaraes, C.P.; Yoder, N.C.; Grotenbreg, G.M.; Popp, M.W.;  
Ploegh, H.L. Site-specific N- and C-terminal labeling of a single polypeptide using sortases of 
different specificity. J. Am. Chem. Soc. 2009, 131, 10800–10801. 
62. Lin, C.W.; Ting, A.Y. Transglutaminase-catalyzed site-specific conjugation of small-molecule 
probes to proteins in vitro and on the surface of living cells. J. Am. Chem. Soc. 2006, 128,  
4542–4543. 
63. Chen, I.; Howarth, M.; Lin, W.; Ting, A.Y. Site-specific labeling of cell surface proteins with 
biophysical probes using biotin ligase. Nat. Methods 2005, 2, 99–104. 
64. Vivero-Pol, L.; George, N.; Krumm, H.; Johnsson, K.; Johnsson, N. Multicolor imaging of cell 
surface proteins. J. Am. Chem. Soc. 2005, 127, 12770–12771. 
65. Heal, W.P.; Jovanovic, B.; Bessin, S.; Wright, M.H.; Magee, A.I.; Tate, E.W. Bioorthogonal 
chemical tagging of protein cholesterylation in living cells. Chem. Commun. (Camb) 2011, 47, 
4081–4083. 
66. Cotton, G.J.; Muir, T.W. Peptide ligation and its application to protein engineering. Chem. Biol. 
1999, 6, R247–R256. 
67. Cotton, G.J.; Muir, T.W. Generation of a dual-labeled fluorescence biosensor for Crk-II 
phosphorylation using solid-phase expressed protein ligation. Chem. Biol. 2000, 7, 253–261. 
68. Hofmann, R.M.; Cotton, G.J.; Chang, E.J.; Vidal, E.; Veach, D.; Bornmann, W.; Muir, T.W. 
Fluorescent monitoring of kinase activity in real time: Development of a robust fluorescence-based 
assay for Abl tyrosine kinase activity. Bioorg. Med. Chem. Lett. 2001, 11, 3091–3094. 
69. Muralidharan, V.; Cho, J.; Trester-Zedlitz, M.; Kowalik, L.; Chait, B T.; Raleigh, D.P.; Muir, T.W. 
Domain-specific incorporation of noninvasive optical probes into recombinant proteins. J. Am. 
Chem. Soc. 2004, 126, 14004–14012. 
70. Mukhopadhyay, J.; Kapanidis, A.N.; Mekler, V.; Kortkhonjia, E.; Ebright, Y.W.; Ebright, R.H. 
Translocation of sigma(70) with RNA polymerase during transcription: Fluorescence resonance 
energy transfer assay for movement relative to DNA. Cell 2001, 106, 453–463. 
71. Mekler, V.; Kortkhonjia, E.; Mukhopadhyay, J.; Knight, J.; Revyakin, A.; Kapanidis, A.N.; Niu, W.; 
Ebright, Y.W.; Levy, R.; Ebright, R.H. Structural organization of bacterial RNA polymerase 
holoenzyme and the RNA polymerase-promoter open complex. Cell 2002, 108, 599–614. 
72. Xie, N.; Elangwe, E.N.; Asher, S.; Zheng, Y.G. A dual-mode fluorescence strategy for screening 
HAT modulators. Bioconjug. Chem. 2009, 20, 360–366. 
73. Scheibner, K.A.; Zhang, Z.; Cole, P.A. Merging fluorescence resonance energy transfer and 
expressed protein ligation to analyze protein-protein interactions. Anal. Biochem. 2003, 317, 
226–232. 
74. Becker, C.F.; Seidel, R.; Jahnz, M.; Bacia, K.; Niederhausen, T.; Alexandrov, K.; Schwille, P.; 
Goody, R.S.; Engelhard, M. C-terminal fluorescence labeling of proteins for interaction studies 
on the single-molecule level. Chembiochem 2006, 7, 891–895. 
Molecules 2013, 18 463 
 
 
75. Yi, L.; Sun, H.; Itzen, A.; Triola, G.; Waldmann, H.; Goody, R.S.; Wu, Y.W. One-pot  
dual-labeling of a protein by two chemoselective reactions. Angew. Chem. Int. Ed. Engl. 2011, 
50, 8287–8290. 
76. Yi, L.; Sun, H.; Wu, Y.W.; Triola, G.; Waldmann, H.; Goody, R.S. A highly efficient strategy for 
modification of proteins at the C terminus. Angew. Chem. Int. Ed. Engl. 2010, 49, 9417–9421. 
77. Tolbert, T.J.; Wong, C.H. New methods for proteomic research: Preparation of proteins with  
N-terminal cysteines for labeling and conjugation. Angew. Chem. Int. Ed. Engl. 2002, 41,  
2171–2174. 
78. Iakovenko, A.; Rostkova, E.; Merzlyak, E.; Hillebrand, A.M.; Thomä, N.H.; Goody, R.S.; 
Alexandrov, K. Semi-synthetic Rab proteins as tools for studying intermolecular interactions. 
FEBS Lett. 2000, 468, 155–158. 
79. Wu, Y.W.; Goody, R.S.; Alexandrov, K. Intein-mediated construction of a library of fluorescent 
Rab GTPase probes. ChemBioChem 2011, 12, 2813–2821. 
80. De Rosa, L.; Cortajarena, A.L.; Romanelli, A.; Regan, L.; D’Andrea, L.D. Site-specific protein 
double labeling by expressed protein ligation: Applications to repeat proteins. Org. Biomol. Chem. 
2012, 10, 273–280. 
81. Deniz, A.A.; Laurence, T.A.; Beligere, G.S.; Dahan, M.; Martin, A.B.; Chemla, D.S.; Dawson, P.E.; 
Schultz, P.G.; Weiss, S. Single-molecule protein folding: Diffusion fluorescence resonance 
energy transfer studies of the denaturation of chymotrypsin inhibitor 2. Proc. Natl. Acad. Sci. USA 
2000, 97, 5179–5184. 
82. Appleby-Tagoe, J.H.; Thiel, I.V.; Wang, Y.; Mootz, H.D.; Liu, X.Q. Highly efficient and more 
general cis- and trans-splicing inteins through sequential directed evolution. J. Biol. Chem. 2011, 
286, 34440–34447. 
83. Yang, J.Y.; Yang, W.Y. Site-specific two-color protein labeling for FRET studies using split 
inteins. J. Am. Chem. Soc. 2009, 131, 11644–11645. 
84. Zettler, J.; Schütz, V.; Mootz, H.D. The naturally split Npu DnaE intein exhibits an 
extraordinarily high rate in the protein trans-splicing reaction. FEBS Lett. 2009, 583, 909–914. 
85. Shah, N.H.; Dann, G.P.; Vila-Perelló, M.; Liu, Z.; Muir, T.W. Ultrafast protein splicing is 
common among cyanobacterial split inteins: Implications for protein engineering. J. Am. Chem. Soc. 
2012, 134, 11338–11341. 
86. Bellmann-Sickert, K.; Baumann, L.; Beck-Sickinger, A.G. Selective labelling of stromal  
cell-derived factor 1alpha with carboxyfluorescein to study receptor internalisation. J. Pept. Sci. 
2010, 16, 568–574. 
87. Pellois, J.P.; Hahn, M.E.; Muir, T.W. Simultaneous triggering of protein activity and fluorescence. 
J. Am. Chem. Soc. 2004, 126, 7170–7171. 
88. Hahn, M.E.; Pellois, J.P.; Vila-Perello, M.; Muir, T.W. Tunable photoactivation of a  
post-translationally modified signaling protein and its unmodified counterpart in live cells. 
Chembiochem 2007, 8, 2100–2105. 
89. Chaisemartin, L.; Chinestra, P.; Favre, G.; Blonski, C.; Faye, J.C. Synthesis and application of a 
N-1' fluorescent biotinyl derivative inducing the specific carboxy-terminal dual labeling of a 
novel RhoB-selective scFv. Bioconjug. Chem. 2009, 20, 847–855. 
Molecules 2013, 18 464 
 
 
90. Schuler, B.; Pannell, L.K. Specific labeling of polypeptides at amino-terminal cysteine residues 
using Cy5-benzyl thioester. Bioconjug. Chem. 2002, 13, 1039–1043. 
91. Yeo, D.S.; Srinivasan, R.; Uttamchandani, M.; Chen, G.Y.; Zhu, Q.; Yao, S.Q. Cell-permeable 
small molecule probes for site-specific labeling of proteins. Chem. Commun. (Camb) 2003, 2003, 
2870–2871. 
92. Gentle, I.E.; de Souza, D.P.; Baca, M. Direct production of proteins with N-terminal cysteine for 
site-specific conjugation. Bioconjug. Chem. 2004, 15, 658–663. 
93. Giriat, I.; Muir, T.W. Protein semi-synthesis in living cells. J. Am. Chem. Soc. 2003, 125, 7180–7181. 
94. Dhar, T.; Mootz, H.D. Modification of transmembrane and GPI-anchored proteins on living cells 
by efficient protein trans-splicing using the Npu DnaE intein. Chem. Commun. (Camb) 2011, 47, 
3063–3065. 
95. Xu, R.; Ayers, B.; Cowburn, D.; Muir, T.W. Chemical ligation of folded recombinant proteins: 
Segmental isotopic labeling of domains for NMR studies. Proc. Natl. Acad. Sci. USA 1999, 96, 
388–393. 
96. Xu, R.; Liu, D.; Cowburn, D. Abl kinase constructs expressed in bacteria: Facilitation of structural 
and functional studies including segmental labeling by expressed protein ligation. Mol. Biosyst. 
2012, 8, 1878–1885. 
97. Camarero, J.A.; Shekhtman, A.; Campbell, E.A.; Chlenov, M.; Gruber, T.M.; Bryant, D.A.; 
Darst, S.A.; Cowburn, D.; Muir, T.W. Autoregulation of a bacterial sigma factor explored by 
using segmental isotopic labeling and NMR. Proc. Natl. Acad. Sci. USA 2002, 99, 8536–8541. 
98. Clerico, E.M.; Zhuravleva, A.; Smock, R.G.; Gierasch, L.M. Segmental isotopic labeling of the 
Hsp70 molecular chaperone DnaK using expressed protein ligation. Biopolymers 2010, 94, 742–752. 
99. Vitali, F.; Henning, A.; Oberstrass, F.C.; Hargous, Y.; Auweter, S.D.; Erat, M.; Allain, F.H. 
Structure of the two most C-terminal RNA recognition motifs of PTB using segmental isotope 
labeling. EMBO J. 2006, 25, 150–162. 
100. Skrisovska, L.; Allain, F.H. Improved segmental isotope labeling methods for the NMR study of 
multidomain or large proteins: Application to the RRMs of Npl3p and hnRNP L. J. Mol. Biol. 
2008, 375, 151–164. 
101. Chen, J.; Wang, J. A segmental labeling strategy for unambiguous determination of domain-domain 
interactions of large multi-domain proteins. J. Biomol. NMR 2011, 50, 403–410. 
102. Zhao, W.; Zhang, Y.; Cui, C.; Li, Q.; Wang, J. An efficient on-column expressed protein ligation 
strategy: Application to segmental triple labeling of human apolipoprotein E3. Protein Sci. 2008, 
17, 736–747. 
103. Castaneda, C.A.; Spasser, L.; Bavikar, S.N.; Brik, A.; Fushman, D. Segmental isotopic labeling 
of ubiquitin chains to unravel monomer-specific molecular behavior. Angew. Chem. Int. Ed. Engl. 
2011, 50, 11210–11214. 
104. Romanelli, A.; Shekhtman, A.; Cowburn, D.; Muir, T.W. Semisynthesis of a segmental isotopically 
labeled protein splicing precursor: NMR evidence for an unusual peptide bond at the  
N-extein-intein junction. Proc. Natl. Acad. Sci. USA 2004, 101, 6397–6402. 
105. Frutos, S.; Goger, M.; Giovani, B.; Cowburn, D.; Muir, T.W. Branched intermediate formation 
stimulates peptide bond cleavage in protein splicing. Nat. Chem. Biol. 2010, 6, 527–533. 
Molecules 2013, 18 465 
 
 
106. Anderson, L.L.; Marshall, G.R.; Crocker, E.; Smith, S.O.; Baranski, T.J. Motion of carboxyl 
terminus of Galpha is restricted upon G protein activation. A solution NMR study using 
semisynthetic Galpha subunits. J. Biol. Chem. 2005, 280, 31019–31026. 
107. Blaschke, U.K.; Silberstein, J.; Muir, T.W. Protein engineering by expressed protein ligation. 
Meth. Enzymol. 2000, 328, 478–496. 
108. Karagöz, G.E; Sinnige, T.; Hsieh, O.; Rüdiger, S.G.D. Expressed protein ligation for a large 
dimeric protein. Protein Eng. Des. Sel. 2011, 24, 495–501. 
109. Moran, S.D.; Woys, A.M.; Buchanan, L.E.; Bixby, E.; Decatur, S.M.; Zanni, M.T.  
Two-dimensional IR spectroscopy and segmental 13C labeling reveals the domain structure of 
human γD-crystallin amyloid fibrils. Proc. Natl. Acad. Sci. USA 2012, 128, 3329–3334. 
110. Moran, S.D.; Decatur, S.M.; Zanni, M.T. Structural and Sequence Analysis of the Human  
γD-Crystallin Amyloid Fibril Core Using 2D IR Spectroscopy, Segmental (13)C Labeling, and 
Mass Spectrometry. J. Am. Chem. Soc. 2012, 134, 18410–18416. 
111. Busche, A.E.; Aranko, A.S.; Talebzadeh-Farooji, M.; Bernhard, F.; Dotsch, V.; Iwai, H. 
Segmental isotopic labeling of a central domain in a multidomain protein by protein trans-splicing 
using only one robust DnaE intein. Angew. Chem. Int. Ed. Engl. 2009, 48, 6128–6131. 
112. Minato, Y.; Ueda, T.; Machiyama, A.; Shimada, I.; Iwai, H. Segmental isotopic labeling of a  
140 kDa dimeric multi-domain protein CheA from Escherichia coli by expressed protein ligation 
and protein trans-splicing. J. Biomol. NMR 2012, 53, 191–207. 
113. Yagi, H.; Tsujimoto, T.; Yamazaki, T.; Yoshida, M.; Akutsu, H. Conformational change of  
H+-ATPase beta monomer revealed on segmental isotope labeling NMR spectroscopy. J. Am. 
Chem. Soc. 2004, 126, 16632–16638. 
114. Yagi, H.; Kajiwara, N.; Iwabuchi, T.; Izumi, K.; Yoshida, M.; Akutsu, H. Stepwise propagation 
of the ATP-induced conformational change of the F1-ATPase beta subunit revealed by NMR.  
J. Biol. Chem. 2009, 284, 2374–2382. 
115. Muona, M.; Aranko, A.S.; Iwai, H. Segmental isotopic labelling of a multidomain protein by 
protein ligation by protein trans-splicing. Chembiochem 2008, 9, 2958–2961. 
116. Muona, M.; Aranko, A.S.; Raulinaitis, V.; Iwai, H. Segmental isotopic labeling of multi-domain 
and fusion proteins by protein trans-splicing in vivo and in vitro. Nat. Protoc. 2010, 5, 574–587. 
117. Zuger, S.; Iwai, H. Intein-based biosynthetic incorporation of unlabeled protein tags into 
isotopically labeled proteins for NMR studies. Nat. Biotechnol. 2005, 23, 736–740. 
118. Kobayashi, H.; Yoshida, T.; Inouye, M. Significant enhanced expression and solubility of human 
proteins in Escherichia coli by fusion with protein S from Myxococcus xanthus. Appl. Environ. 
Microbiol. 2009, 75, 5356–5362. 
119. Kobayashi, H.; Swapna, G.V.; Wu, K.P.; Afinogenova, Y.; Conover, K.; Mao, B.; Montelione, G.T.; 
Inouye, M. Segmental isotope labeling of proteins for NMR structural study using a protein S tag 
for higher expression and solubility. J. Biomol. NMR 2012, 52, 303–313. 
© 2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
